Close Brothers advised Varian Medical Systems on the sale of the Research Instruments business of ACCEL Instruments

Frankfurt/Main, 7 April 2009

Varian Medical Systems, Inc., the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy, sold its Research Instruments business unit of ACCEL Instruments GmbH to Bruker Advanced Supercon, Inc., a subsidiary of Bruker Corporation.

The transaction creates a global leader in superconducting technologies for alternative energy research and next-generation energy infrastructure.

The Research Instruments ("RI") business acquired by Bruker is a world leader in the development and manufacturing of a wide variety of advanced superconducting and other subunits and systems for physics and energy research, and other scientific applications. RI products include electron and ion linear accelerators, superconducting and normal conducting accelerator cavities, insertion devices, other accelerator components, neutron source subunits, specialized superconducting magnets, superconducting devices, X-ray and particle beamlines, as well as vacuum and cryosystems.

Close Brothers acted as exclusive financial adviser to Varian Medical Systems on this transaction.

Background information on ACCEL Instruments GmbH

Bergisch-Gladbach based ACCEL Instruments GmbH is a subsidiary of Varian Medical Systems, Inc. ACCEL was founded in 1993 as a spin-off from Siemens AG and was acquired by Varian in 2007. Besides the Research Instruments business, ACCEL operates a Proton Therapy business unit being a leading manufacturer of proton therapy systems for the treatment of cancer.
www.accel.de

Background information on Varian Medical Systems, Inc.

Varian Medical Systems, Inc. (NYSE: VAR, market capitalization: USD 3.7 billion) is headquartered in Palo Alto, California. The company supplies devices and software for comprehensive cancer clinics, radiotherapy centres and medical oncology practices. Varian is the market leader in radiotherapy in North America and Europe. In the fiscal year 2008, the company reported sales of USD 2.1 billion, more than 50% generated outside North America.
www.varian.com

Background information on Bruker Advanced Supercon

Bruker Advanced Supercon is a global leader in the development and industrial production of low-temperature superconducting wires. Bruker Advanced Supercon is a subsidiary of Bruker Corporation (NASDAQ: BRKR, market capitalization: USD 1.0 billion), a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. Bruker Corporation, headquartered in Billerica, Massachusetts, reported sales of USD 1.1 billion in 2008.
www.advancedsupercon.com and www.bruker.com

Background information on Close Brothers

Close Brothers is Europe’s largest, independent investment bank focused exclusively on mid-market transactions. Close Brothers GmbH, Germany, and Close Brothers AG, Switzerland, are part of Close Brothers Group plc., the LSE listed UK investment bank. Close Brothers has 2,500 employees worldwide of which more than 150 are based in Germany and Switzerland. Close Brothers International has a global presence with offices in all important financial centres in Europe, Asia and the USA. Close Brothers offers independent corporate finance advice in four areas: Mergers and Acquisitions, Corporate Restructuring, Debt Advisory and dedicated advice to the Private Equity industry. Furthermore, Close Brothers, along with Close Brothers Seydler Bank AG, Frankfurt, is one of the leading Designated Sponsors at the German stock exchange.
www.closebrothers.de and www.closebrothers.ch